- Home
- TK vs EVMN Comparison
TK vs EVMN Comparison
Compare TK & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TK | EVMN |
|---|---|---|
| Founded | 1973 | 2020 |
| Country | Bermuda | United States |
| Employees | N/A | 48 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 869.1M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | TK | EVMN |
|---|---|---|
| Price | $10.70 | $24.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $43.88 |
| AVG Volume (30 Days) | ★ 506.6K | 481.8K |
| Earning Date | 05-13-2026 | 06-11-2026 |
| Dividend Yield | ★ 15.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.12 | $13.89 |
| 52 Week High | $14.38 | $33.20 |
Technical Indicators
Market Signals| Indicator | TK | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 32.98 | 60.30 |
| Support Level | $9.11 | $21.32 |
| Resistance Level | $14.12 | $25.50 |
| Average True Range (ATR) | 0.51 | 1.57 |
| MACD | -0.06 | 0.55 |
| Stochastic Oscillator | 8.14 | 73.48 |
Price Performance
Historical ComparisonAbout TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.